Target isoforms are an overlooked challenge and opportunity in chimeric antigen receptor cell therapy

Mike Bogetofte Barnkob, Kristoffer Vitting-Seerup, Lars Rønn Olsen

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

1 Downloads (Pure)

Dokumenter og links

@article{dba3d5af0c604307a7af21463a0e8bea,

title = "Target isoforms are an overlooked challenge and opportunity in chimeric antigen receptor cell therapy",

author = "Barnkob, {Mike Bogetofte} and Kristoffer Vitting-Seerup and Olsen, {Lars R{\o}nn}",

year = "2022",

month = apr,

day = "20",

doi = "10.1093/immadv/ltac009",

language = "English",

volume = "2",

journal = "Immunotherapy Advances",

number = "1",

}

TY - JOUR

T1 - Target isoforms are an overlooked challenge and opportunity in chimeric antigen receptor cell therapy

AU - Barnkob, Mike Bogetofte

AU - Vitting-Seerup, Kristoffer

AU - Olsen, Lars Rønn

PY - 2022/4/20

Y1 - 2022/4/20

U2 - 10.1093/immadv/ltac009

DO - 10.1093/immadv/ltac009

M3 - Comment/debate

VL - 2

JO - Immunotherapy Advances

JF - Immunotherapy Advances

IS - 1

M1 - ltac009

ER -